Emicizumab para el tratamiento primera línea en profilaxis Hemofilia A severa con y sin inhibidores / Emicizumab for first-line treatment in prophylaxis Severe hemophilia A with and without inhibitors
San Salvador; ISSS; nov. 2023.
Non-conventional
in Es
| BRISA
| ID: biblio-1554191
Responsible library:
BR1.1
Full text:
1
Collection:
05-specialized
Database:
BRISA
Main subject:
Immunoglobulin G
/
Antibodies, Bispecific
/
Hemophilia A
Type of study:
Health_technology_assessment
Limits:
Humans
Language:
Es
Year:
2023
Document type:
Non-conventional
Country of publication: